Meet the Team

DAVID R. TABATADZE, PhD
President and Founder of ZATA Aesthetics, Inc.

Dr. David Tabatadze holds an MS in organic chemistry from Javakhishvili University in the Republic of Georgia, a PhD in bioorganic chemistry from the Institute of Bioorganic Chemistry in Novosibirsk, Russia, and has undergone post-doctoral training in the field of oligotherapeutics at the Worcester Foundation for Biomedical Research in Worcester, MA.

Over the last two decades, he has also gained unique experience and expertise in the field of aesthetic medicine. From 2000 to 2011, Dr. Tabatadze worked for Palomar Inc., where he served as the principal bio-scientist. His responsibilities included preclinical evaluation and optimization of light-based medical devices for the fields of aesthetic medicine and dermatology.

Since 2013, Dr. Tabatadze has led histopathological evaluations of several dozen international and domestic origin power-based devices at ZATA Pharmaceuticals, Inc, securing their FDA clearances via 510K and De Novo pathways.

In 2023, Dr. Tabatadze founded ZATA Aesthetics, Inc. (ZAI) as an independent entity from its parent company, ZATA Pharmaceuticals, Inc. This new company is fully dedicated to assisting current and future clientele in the optimization and clearance of their novel power-based medical devices.

Victor Ilyashenko, PhD
Vice President of Business Development

Dr. Victor Ilyashenko holds a Master of Science degree in Chemical Engineering from the Lomonosov Institute of Fine Chemical Technology in Moscow, as well as a Ph.D. in Physical Chemistry from the Kurnakov Institute, Academy of Sciences of the USSR. Dr. Victor Ilyashenko spent most of his R&D career at an early-stage startup company, which has now grown to become the largest manufacturer of optical fiber laser in the world; IPG Photonics. Dr. Ilyashenko led all aspects of development and patenting of related organic and analytical chemistry at IPG. After the co-founder/CEO of the company (Dr. Valentin Gapontsev,1939-2021) passed away, the upper management's business strategy shifted to focus on the manufacturing and commercialization of products Dr. Ilyashenko had already developed. This shift inspired Dr. Ilyashenko to consider new challenges and opportunities. After meeting with Dr. David Tabatadze, President of ZATA Aesthetics, Inc. (ZAI), and gaining familiarity with the ongoing and intended projects of the company, he was welcomed on board as the Vice President of Business Development. His tremendous experience and prior contributions to power- based devices will be instrumental in the further development and commercialization of ZAI's ongoing medical and aesthetic projects. At ZATA Aesthetics, Inc., under the coordination of Dr. Tabatadze, he oversees and manages all aspects of business development and establishes strategic partnerships

IVAN B. YANACHKOV, PhD
Vice President of Business Development

Dr. Ivan Yanachkov holds an MS in Organic Synthesis from the University of Chemical Technology and Metallurgy in Sofia, Bulgaria. He also has a double PhD in Organic Chemistry, earned from the University of Chemical Technology and Metallurgy in Sofia, Bulgaria, and Clark University in Worcester, MA. Additionally, he has completed post-doctoral training in the field of medicinal chemistry and pharmacology at the University of Massachusetts Medical School.

Dr. Yanachkov has notable accomplishments in the field of medicinal and analytical chemistry. He led the development of chemical methodologies that enabled the synthesis of a new generation of oligotherapeutics, and a novel class of anti-pathogen compounds.

Before joining ZATA, he worked at GLSynthesis, Inc., where he developed and patented a highly potent antiplatelet drug candidate currently in the late stages of preclinical development.